Cancer Family
Anaplastic Malignant Neoplasm
CI-CAN-00000065Explore in graph →
546 active trials4 approved drugs57 evidence items
- NCIt
- C36025
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000065Explore in graph →
Clinical trials
2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (324)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04802447 | SurVaxM Expanded Access Protocol(EAP) | no longer available | — | — | Roswell Park Cancer InstituteOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT05936216 | TVI-Brain-1 in Expanded Access Patient | no longer available | — | — | TVAX BiomedicalINDUSTRY | 1 | Oct 1, 2024 | clinicaltrials |
| NCT05551013 | Treatment of Recurrent GBM With APG-157 Via Expanded Access | no longer available | — | — | Aveta Biomics, Inc.INDUSTRY | 0 | Aug 9, 2024 | clinicaltrials |
| NCT06439849 | Single Patient Compassionate Use / Expanded Access L-S-Gboxin (Lyophilized Form of S-Gboxin) for the Treatment of Diffuse Midline Glioma(TRIANGLE) | no longer available | — | — | Petrov, AndreyOTHER | 0 | Jul 16, 2024 | clinicaltrials |
| NCT04321694 | Expanded Access for KHK2455 | no longer available | — | — | Kyowa Kirin, Inc.INDUSTRY | 0 | Apr 25, 2024 | clinicaltrials |
| NCT04599647 | EAP for the Treatment of Glioblastoma With PVSRIPO | no longer available | — | — | Istari Oncology, Inc.INDUSTRY | 1 | Jun 29, 2022 | clinicaltrials |
| NCT04289155 | Individual Patient Compassionate Use of GX-I7 | no longer available | — | — | Genexine, Inc.INDUSTRY | 1 | Mar 17, 2022 | clinicaltrials |
| NCT03460782 | An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas | no longer available | — | — | Center Trials & TreatmentOTHER | 8 | Nov 8, 2019 | clinicaltrials |
| NCT03123952 | Expanded Access to ABT-414 | no longer available | — | — | AbbVieINDUSTRY | 0 | Jul 15, 2019 | clinicaltrials |
| NCT03311542 | Expanded Access for Pembrolizumab (MK-3475) | no longer available | — | — | Center Trials & TreatmentOTHER | 4 | Jan 10, 2018 | clinicaltrials |
| NCT03068650 | Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut(CDX-110) | no longer available | — | — | Celldex TherapeuticsINDUSTRY | 0 | Oct 18, 2017 | clinicaltrials |
| NCT02755987 | Expanded Access to ANG1005 for Individual Patients | no longer available | — | — | Angiochem IncINDUSTRY | 1 | Jun 7, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Sep 16, 2025source: clinicaltrials